feed,title,long_url,short_url
Benzinga,Bluebird bio's Neurological Disorder Gene Therapy Wins CHMP Backing for Approval,https://benzinga.com/general/biotech/21/05/21235185/bluebird-bios-neurological-disorder-gene-therapy-wins-chmp-backing-for-approval,https://j.mp/3hL4Fp4
